Nakamura Seigo

Affiliation and department：
Papers (10)：

Naoki Hayashi, Yuko Takahashi, Naoko Matsuda, Hiroko Tsunoda, Atsushi Yoshida, Koyu Suzuki, Seigo Nakamura, Hideko Yamauchi. The Prognostic Effect of Changes in Tumor Stage and Nodal Status After Neoadjuvant Chemotherapy in Each Primary Breast Cancer Subtype. Clinical breast cancer. 2018. 18. 2. e219-e229-e229
Hideko Yamauchi, Chizuko Nakagawa, Makoto Kobayashi, Yusuke Kobayashi, Toshiki Mano, Seigo Nakamura, Masami Arai. Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers. Breast Cancer. 2018. 25. 2. 141-150
Joe Yeong, Aye Aye Thike, Murasaki Ikeda, Jeffrey Chun Tatt Lim, Bernett Lee, Seigo Nakamura, Jabed Iqbal, Puay Hoon Tan. Caveolin-1 expression as a prognostic marker in triple negative breast cancers of Asian women. Journal of Clinical Pathology. 2018. 71. 2. 161-167
Hidetoshi Kawaguchi, Norikazu Masuda, Takahiro Nakayama, Kenjiro Aogi, Keisei Anan, Yoshinori Ito, Shoichiro Ohtani, Nobuaki Sato, Shigehira Saji, Toshimi Takano, et al. Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study. Current Medical Research and Opinion. 2018. 34. 1. 49-54
Naoko Matsuda, Kumiko Kida, Sachiko Ohde, Koyu Suzuki, Hideko Yamauchi, Seigo Nakamura, Hiroko Tsunoda. Change in sonographic brightness can predict pathological response of triple-negative breast cancer to neoadjuvant chemotherapy. Breast cancer (Tokyo, Japan). 2018. 25. 1. 43-49

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page